Links Between Child and Adolescent Psychiatric Disorders and Cardiovascular Risk

被引:29
|
作者
Goldstein, Benjamin, I [1 ,2 ]
Korczak, Daphne J. [3 ]
机构
[1] Univ Toronto, Fac Med, Ctr Youth Bipolar Disorder, Dept Psychiat,Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[2] Univ Toronto, Fac Med, Ctr Youth Bipolar Disorder, Dept Pharmacol,Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Hosp Sick Children, Fac Med, Dept Psychiat, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CORONARY-HEART-DISEASE; MAJOR DEPRESSIVE DISORDER; AUTISM SPECTRUM DISORDERS; BODY-MASS INDEX; BIPOLAR DISORDER; CIGARETTE-SMOKING; ANXIETY DISORDERS; MENTAL-DISORDERS;
D O I
10.1016/j.cjca.2020.06.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This narrative review, with an emphasis on children and adolescents, addresses the link between 5 psychiatric disorders and cardiovascular risk: attention deficit hyperactivity disorder, autism spectrum disorders, anxiety disorders, depression, and bipolar disorders. The evidence regarding cardiovascular risk factors, noninvasive measures of early atherosclerosis, and cardiovascular disease prevalence and/or mortality is summarized. Whereas multiple studies have examined stimulant treatment of attention deficit hyperactivity disorder in relation to cardiovascular death, and autonomic-vagal function in autism spectrum disorders, little is known regarding atherosclerotic cardiovascular disease in patients with these conditions. For anxiety disorders, there is a gap in knowledge regarding cardiovascular risk in clinical samples of youth. In contrast to the adult literature, there are few studies regarding depression diagnoses, as opposed to self-reported symptoms, in relation to cardiovascular risk in youth. For bipolar disorder, youth studies focused on epidemiologic samples and various mood-stabilizing medications are warranted. General recommendations for future research include: larger samples, prospective repeated measures studies, and the integration of clinical and biological mediators with noninvasive measures of early atherosclerosis. Overall, the potential implications of cardiovascular risk factors are multiplied in youth with psychiatric conditions, because these risk factors are relevant not only to cardiovascular disease but to mental health and cognitive function. A shift in thinking regarding treatment paradigms for youth with psychiatric disorders is warranted. Pending changes in clinical practice guidelines and care delivery models, patients, families, clinicians, and policy makers can act on currently available information to reduce cardiovascular risk among children and adolescents with psychiatric disorders.
引用
收藏
页码:1394 / 1405
页数:12
相关论文
共 50 条
  • [21] Book review of Pharmacotherapy of Child and Adolescent Psychiatric Disorders
    Lohr, W. David
    ASIA-PACIFIC PSYCHIATRY, 2014, 6 (01) : 112 - 113
  • [24] Prevalence of child and adolescent psychiatric disorders in southeast Brazil
    Fleitlich-Bilyk, B
    Goodman, R
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (06): : 727 - 734
  • [25] A systematic review on olfaction in child and adolescent psychiatric disorders
    Martin Schecklmann
    Christina Schwenck
    Regina Taurines
    Christine Freitag
    Andreas Warnke
    Manfred Gerlach
    Marcel Romanos
    Journal of Neural Transmission, 2013, 120 : 121 - 130
  • [26] ALS in Danish Registries: Heritability and links to psychiatric and cardiovascular disorders
    Trabjerg, Betina B.
    Garton, Fleur C.
    van Rheenen, Wouter
    Fang, Fang
    Henderson, Robert D.
    Mortensen, Preben Bo
    Agerbo, Esben
    Wray, Naomi R.
    NEUROLOGY-GENETICS, 2020, 6 (02)
  • [27] The Therapeutic Potential of Prebiotics and Probiotics in Child and Adolescent Psychiatric Disorders
    Schneider, Andrea
    Zeiler, Michael
    Kopp, Konstantin
    Wagner, Gudrun
    Karwautz, Andreas
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2023, 51 (06): : 441 - 450
  • [28] Pharmacotherapy for child and adolescent psychiatric disorders, second edition.
    Matthews, AM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (09): : 1134 - 1134
  • [29] Fecal Microbiota Transplants in the Context of (Child and Adolescent) Psychiatric Disorders
    Trinh, Stefanie
    Keller, Lara
    Herpertz-Dahlmann, Beate
    Seitz, Jochen
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2023, 51 (06): : 431 - 440
  • [30] Aripiprazole in child and adolescent psychiatric disorders: Safety, tolerability, and pharmacokinetics
    Nyilas, M.
    Auby, P.
    Mallikaarjun, S.
    Forbes, A.
    Carson, W. H.
    EUROPEAN PSYCHIATRY, 2007, 22 : S130 - S130